Leukemogenic Function of TIM-3, a Leukemia Stem Cell Marker, in Acute Myelogenous Leukemia and Myelodysplastic Syndromes

被引：2
|
作者：
Kikushige, Yoshikane [1 ]
Shima, Takahiro [1 ]
Yuda, Junichiro [1 ]
Miyamoto, Toshihiro [1 ]
Akashi, Koichi [1 ]
机构：
[1] Kyushu Univ, Grad Sch Med Sci, Dept Med & Biosyst Sci, Fukuoka 812, Japan
来源：
BLOOD | 2012年 / 120卷 / 21期
关键词：
D O I：
10.1182/blood.V120.21.2983.2983
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2983
引用
收藏
页数：2
相关论文
共 50 条
  • [1] LEUKEMOGENIC FUNCTION OF TIM-3, A LEUKEMIA STEM CELL MARKER, IN ACUTE MYELOGENOUS LEUKEMIA AND MYELODYSPLASTIC SYNDROMES
    Kikushige, Y.
    Yuda, J.
    Shima, T.
    Miyamoto, T.
    Akashi, K.
    [J]. HAEMATOLOGICA, 2013, 98 : 16 - 16
  • [2] TIM-3 as a therapeutic target for malignant stem cells in acute myelogenous leukemia
    Kikushige, Yoshikane
    Akashi, Koichi
    [J]. HEMATOPOIETIC STEM CELLS VIII, 2012, 1266 : 118 - 123
  • [3] Tim-3 as a leukemia stem cell specific marker expressing on bone marrow mononuclear cells is a factor for prognosis evaluation in patients with acute myelogenous leukemia
    Li, Xiang-Xin
    He, Xiao-Peng
    Ma, Chun-Hong
    Wang, Lu-Qun
    Li, Hao
    Li, Fang-Lin
    Hou, Ming
    Chen, Xue-Liang
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (06): : 10979 - 10986
  • [4] TIM-3 as a novel therapeutic target for eradicating acute myelogenous leukemia stem cells
    Yoshikane Kikushige
    Toshihiro Miyamoto
    [J]. International Journal of Hematology, 2013, 98 : 627 - 633
  • [5] TIM-3 as a novel therapeutic target for eradicating acute myelogenous leukemia stem cells
    Kikushige, Yoshikane
    Miyamoto, Toshihiro
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 98 (06) : 627 - 633
  • [6] Proteasome Inhibition in Myelodysplastic Syndromes and Acute Myelogenous Leukemia Cell Lines
    Liesveld, Jane L.
    Rosell, Karen E.
    Bechelli, Jeremy
    Lu, Chaohui
    Messina, Patti
    Mulford, Deborah
    Ifthikharuddin, J. J.
    Jordan, Craig T.
    Phillips, Gordon L., II
    [J]. CANCER INVESTIGATION, 2011, 29 (07) : 439 - 450
  • [7] Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in myelodysplastic syndromes and acute myelogenous leukemia
    Valcarcel, David
    Martino, Rodrigo
    [J]. CURRENT OPINION IN ONCOLOGY, 2007, 19 (06) : 660 - 666
  • [8] Identification of TIM-3 as a Leukemic Stem Cell Surface Molecule in Primary Acute Myeloid Leukemia
    Kikushige, Yoshikane
    Miyamoto, Toshihiro
    [J]. ONCOLOGY, 2015, 89 : 28 - 32
  • [9] Genetics of donor cell leukemia in acute myelogenous leukemia and myelodysplastic syndrome
    Williams, Lacey
    Doucette, Kimberley
    Karp, Judith E.
    Lai, Catherine
    [J]. BONE MARROW TRANSPLANTATION, 2021, 56 (07) : 1535 - 1549
  • [10] Genetics of donor cell leukemia in acute myelogenous leukemia and myelodysplastic syndrome
    Lacey Williams
    Kimberley Doucette
    Judith E. Karp
    Catherine Lai
    [J]. Bone Marrow Transplantation, 2021, 56 : 1535 - 1549
12345